J. Erin Dienes

Dr. J. Erin Dienes

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMaxwell B Baker
Maxwell B Baker
DBDhanesh D. Binda
Dhanesh D. Binda
Ala NozariAla Nozari
Ala Nozari
JKJoseph Kennedy
Joseph Kennedy
JDJ. Erin Dienes
J. Erin Dienes
WBWilliam E Baker
William E Baker
Background: Rising cannabis use poses significant challenges in the administration of general anesthetics, particularly propofol, due to potential alterations in pharmacodynamics caused by tetrahydrocannabinol and its interactions with central nervous system receptors. This systematic review and meta-analysis aims to consolidate the existing literature to quantify propofol requirements in cannabis users, highlighting the complex relationship between cannabis use and anesthetic management. Methods: A systematic search of English-language literature was conducted to identify studies with data on propofol dosing in adult cannabis users. Propofol requirements were defined as the total intraoperative dose needed to achieve and maintain adequate sedation or anesthesia, assessed using parameters like monitoring and procedural tolerance. A random-effects model was used with DerSimonian–Laird estimations for pooled effect sizes and 95% confidence intervals. Heterogeneity was assessed using I2 and Cochran’s Q statistics, and sensitivity analysis was conducted by grouping publications by design, size, and quality. Results: Eight qualified studies were identified with 2268 patients included. Patients who used cannabis were typically younger and more likely to smoke tobacco than non-users. Propofol requirements were significantly higher in cannabis users, who required an average additional dose of 47.33 mg compared to non-users. Subgroup analyses revealed that cannabis users undergoing general anesthesia needed an additional 30.57 mg intraoperatively, while those undergoing sedation for endoscopic procedures required an additional 53.02 mg. Conclusions: These results underscore the need for personalized anesthetic plans to accommodate physiological variations in cannabis users. However, the lack of standardized definitions for propofol requirements and the heterogeneity across studies necessitate caution in interpretation. The observed increase in propofol requirements suggests altered central nervous system sensitivities and receptor changes in cannabis users, emphasizing the need for further research to establish clear definitions, elucidate underlying mechanisms, and refine clinical guidelines for anesthetic management in this population.

10 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RCRobert Canelli
Robert Canelli
JLJoseph Louca
Joseph Louca
MGMauricio Gonzalez
Mauricio Gonzalez
MSMichelle Sia
Michelle Sia
MBMaxwell B Baker
Maxwell B Baker
FBFederico Bilotta
Federico Bilotta
Background/Objectives: Elevated glycemic variability (GV) has been associated with postoperative morbidity. Traditional preoperative fasting guidelines may contribute to high GV by driving the body into catabolism. Enhanced recovery after surgery (ERAS) protocols that include a preoperative carbohydrate load (PCL) reduce hospital length of stay and healthcare costs; however, it remains unclear whether PCL improves GV in surgical patients. The aim of this retrospective study was to determine the effect of a PCL on postoperative GV in diabetic and non-diabetic patients having gynecological surgery. Methods: Retrospective data were collected on patients who had gynecological surgery before and after the rollout of an institutional ERAS protocol that included PCL ingestion. The intervention group included patients who underwent surgery in 2019 and were enrolled in the ERAS protocol and, therefore, received a PCL. The control group included patients who underwent surgery in 2016 and, thus, were not enrolled in the protocol. The primary endpoint was GV, calculated by the coefficient of variance (CV) and glycemic lability index (GLI). Results: A total of 63 patients in the intervention group and 45 in the control were analyzed. GV was not statistically significant between the groups for CV (19.3% vs. 18.6%, p = 0.65) or GLI (0.58 vs. 0.54, p = 0.86). Postoperative pain scores (4.5 vs. 5.2 p = 0.23) and incentive spirometry measurements (1262 vs. 1245 p = 0.87) were not significantly different. A subgroup analysis of patients with and without type 2 diabetes mellitus revealed no significant differences in GV for any of the subgroups. Conclusions: This retrospective review highlights the need for additional GV research, including consensus agreement on a gold standard GV measurement. Large-scale prospective studies are needed to test the effectiveness of the PCL in reducing GV.

29 June 2026 in Clinical Toxicology
Verified
Journal Article
Closed access
MBMaxwell B Baker
Maxwell B Baker
JYJoseph Young
Joseph Young
DBDhanesh D. Binda
Dhanesh D. Binda
JDJ. Erin Dienes
J. Erin Dienes
JKJoseph Kennedy
Joseph Kennedy
Initially discovered as a mucolytic agent in the 1960s, acetylcysteine has been a mainstay in the treatment of acetaminophen toxicity and other injuries involving oxidative stress (Figure 1) [1,2]....

30 December 2025 in Pediatric Anesthesia
Verified
Journal Article
Closed access
CCChristopher M. Conley
Christopher M. Conley
JDJ. Erin Dienes
J. Erin Dienes
XHXuan A. He
Xuan A. He
JCJessica H. Chao
Jessica H. Chao
MCMichael J. Callahan
Michael J. Callahan
JCJoseph Cravero
Joseph Cravero

27 November 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
MBMaxwell B Baker
Maxwell B Baker
RARachel A. Achu-Lopes
Rachel A. Achu-Lopes
HMHaley Mullins
Haley Mullins
DBDhanesh D. Binda
Dhanesh D. Binda
JDJ. Erin Dienes
J. Erin Dienes
NSNicole Z. Spence
Nicole Z. Spence
Background: Inequities in pain management are well documented in chronic pain and outpatient settings, yet little is known about disparities in inpatient Acute Pain Service (APS) care. This study evaluated demographic, clinical, and social factors associated with APS utilization and outcomes in an urban safety-net hospital, with a subgroup analysis of trauma patients who presented with at least three rib fractures. Methods: We performed a retrospective cohort study of two patient populations from our institution: (1) all patients receiving APS consultation from 1 January 2020 to 1 November 2022 (n = 1445) and (2) all patients with traumatic rib fractures during this time, stratified by APS consult status (n = 650). Demographics, insurance, comorbidities, opioid prescribing, and discharge outcomes were analyzed using descriptive statistics, multivariable logistic regression, and log-linear models. As APS consultation criteria were not standardized during the study period, referral patterns reflected routine clinical practice rather than predefined eligibility criteria. Results: Across the full APS cohort, patients were disproportionately represented from vulnerable groups: 30.5% were Black, 81.0% had public insurance, and 32.9% had a substance use disorder (SUD). Methadone use was a strong predictor of non-home discharge, including discharges to a medical facility, hospice, or against medical advice (AMA). In the rib fracture cohort, patients receiving APS consults had significantly higher injury severity scores (Injury Severity Score 17.1 vs. 13.0, p < 0.001). Black patients were less likely to receive APS consult (17.3% vs. 28.8%, p = 0.024). However, this association appeared to be attributable to the younger age and male predominance within this subgroup, as both factors were identified as significant predictors of APS consultation. Conclusions: APS utilization at a high-volume safety-net hospital highlights the intersection of medical vulnerability and structural inequities, with greater involvement among patients who were members of racial and ethnic minorities, publicly insured, or diagnosed with SUD. In trauma populations, younger Black men were over-represented, reinforcing the heightened injury risks Black men may face and the downstream effects on patient care. Taken together, these results highlight how APS involvement acts not only as a marker of increased injury severity but also as an intervention to improve care for vulnerable patient populations. As APS teams regularly serve these populations, they are well-positioned to bridge broader gaps through the integration of addiction and social support services, individualized pain management, and seamless coordination of care across specialties. These findings underscore the need for standardized consultation criteria and integration of social and addiction medicine resources into APS care models.

18 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MBMaxwell B Baker
Maxwell B Baker
HSHimani Sood
Himani Sood
DBDhanesh D. Binda
Dhanesh D. Binda
JDJ. Erin Dienes
J. Erin Dienes
Ala NozariAla Nozari
Ala Nozari
ADAli Daneshmand
Ali Daneshmand
Background/Objectives: Traumatic brain injuries (TBI) account for over a third of all injury-related deaths, predominantly due to motor vehicle collisions (MVC). This study provides a comprehensive analysis of TBI trends in Eastern Massachusetts, focusing on injuries resulting from motorcycle MVCs (mMVC), non-motorcycle MVCs (nmMVC), and pedestrian-vehicle strikes (PVS). Methods: A retrospective analysis was conducted on TBI patients admitted between 2010 and 2020 to Boston Medical Center. TBI severity was assessed using the Glasgow Coma Scale (GCS) on admission (mild: 13–15, moderate: 9–12, severe: 3–8), and outcomes were determined by discharge disability scales. Descriptive and inferential statistics evaluated patient profiles, TBI severity, and group differences. Results: Among the 2901 identified TBI cases from MVCs, 14.1% were mMVCs, 55.1% nmMVCs, and 30.8% PVS. Mortality rates were 3.7% for mMVCs, 2.1% for nmMVCs, and 8.9% for PVS. In 2017, nmMVC-related TBIs decreased by 50% and PVS-related TBIs by 35% (p < 0.01). The PVS group tended to be older (mean age 41.0 years) and more racially diverse, with Asian patients overrepresented. The mMVC group had a significantly skewed gender distribution, with 91% male. TBI severity also varied significantly, with the mMVC and PVS groups experiencing more severe TBIs compared to the nmMVC group (p < 0.001). Discharge outcomes, as assessed by the Cerebral Performance Category (CPC) scale, differed across cohorts (p = 0.0005), with the PVS group showing the most severe outcomes and the nmMVC group demonstrating the highest rate of return to previous function (CPC 0: 5.6%). Conclusions: Our study revealed significant differences in injury severity and outcomes based on the type of vehicular collision. Notably, Asian patients were disproportionately affected by PVS. Older PVS patients exhibited higher mortality rates, while severe TBIs were more common among male mMVC patients. In contrast, nmMVC patients showed better recovery outcomes. Coinciding with the implementation of Boston’s Vision Zero initiative in 2017, decreases in both nmMVC-related and PVS-related TBIs were observed; however, other contributing factors may have also influenced this decline. These findings highlight the urgent need for targeted public health strategies to mitigate TBI risks across diverse populations.